Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.
IISc-incubated Mynvax
IISc-incubated Mynvax
Published on
1 min read

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Bar and Bench - Indian Legal news
www.barandbench.com